Document is current
Any future updates will be listed below
-
Authors
Mnyandu, Njabulo Ziphezinhle
Limani, Shonisani Wendy
Ely, Abdullah
Wadee, Reubina
Arbuthnot, Patrick
Maepa, Mohube Betty
-
Funding
Funding for this research was provided by:
Council for Scientific and Industrial Research
South African National Research Foundation (118022 and 120383)
South African Medical Research Council
Female Academic Leadership Fund
Carnegie/WITS University Enabling grant
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 12 February 2025
First Online: 17 February 2025
Declarations
:
: The use of HBV transgenic mice followed a protocol authorized by University of the Witwatersrand Animal Research and Ethics Committee (#2018/11/57/B, date of approval: 21/11/2018).
: The authors declare no competing interests.
